Progressive Multifocal Leukoencephalopathy (PML)
Progressive Multifocal Leukoencephalopathy (PML) is a severe, life-threatening condition that poses a particular risk for MS patients using immunosuppressive therapies. Awareness of the risk factors, regular monitoring, and open communication with healthcare providers are essential for MS patients considering or currently using these medications.